Xydalba 500 mg powder for concentrate for solution for infusion

DRUG2 trials

Sponsors

Assistance Publique Hopitaux De Paris, Centre Hospitalier Universitaire De Nice

Conditions

Catheter related bloodstream infections due to Staphylococcus aureusprosthetic joint infections

Phase 2

Efficacy of dalbavancin in osteoarticular infections associated with hip, knee and shoulder prostheses PRO-DALBA

Active, not recruitingCTIS2024-518183-12-00

Centre Hospitalier Universitaire De Niceprosthetic joint infections

Start: 2022-03-07Target: 43Updated: 2025-08-08

Phase 3

Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterrelated bloodstream infections due to Staphylococcus aureus [DALICATH]

RecruitingCTIS2024-514952-34-00

Assistance Publique Hopitaux De ParisCatheter related bloodstream infections due to Staphylococcus aureus

Start: 2023-06-23Target: 406Updated: 2025-04-23